Mastodon

Lorem ipsum dolor sit amet...

Marketing Authorization Holder

Pharmgroup, LLC (Russia)

Contact Information

PHARMGROUP LLC (Dietary Supplement) (Russia)

Dosage Form

Bottle OTC Icon Haematogen detskiy “Malysh” Lozenges

Dosage Form, Packaging, and Product Composition

Composition: sweetened whole condensed milk, molasses, sugar syrup, black food albumin, dry maral blood, vanillin.

Content of biologically active substances per 100 g: iron 7-15 mg.

Dosage form and packaging
Bars of 30 g or 50 g. 1 bar per package.

Therapeutic Category

Dietary supplement – additional source of iron

Scope of Application

Of the Haematogen detskiy “Malysh” product

Recommended as a dietary supplement – an additional source of iron.

Indications

  • Use as a dietary supplement to serve as an additional source of iron.
  • Intended for individuals with an increased need for dietary iron.
  • Suitable for use in conditions associated with iron deficiency as determined by a healthcare professional.

ICD codes

ICD-10 code Indication
E61.1 Iron deficiency
ICD-11 code Indication
5B5K.0 Iron deficiency

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer orally with meals. Do not exceed the recommended daily dose.

For children aged 7 to 14 years, the daily dose is 40 g. For adolescents over 14 years and adults, the daily dose is 50 g.

The recommended duration of continuous use is one month. This product is not a medicine and is intended for use as a dietary supplement only.

Adverse Reactions

Adverse reactions are typically associated with individual intolerance to the product’s components.

Reported effects may include allergic reactions such as skin rash, itching, or urticaria. Gastrointestinal discomfort is also possible.

Discontinue use immediately and consult a physician if any adverse reactions occur.

Drug Interactions with Other Medicinal Products and Substances

Concurrent administration with tetracycline antibiotics, quinolones, or levodopa may decrease the absorption of these drugs; maintain a minimum 2-hour interval between intake.

Iron can also reduce the absorption of thyroid hormones and bisphosphonates.

Avoid concurrent use with antacids containing aluminum, calcium, or magnesium, as they can impair iron absorption.

Contraindications for Use in Specific Patient Populations

  • Hypersensitivity or individual intolerance to any component of the product, including sweetened condensed milk, molasses, or albumin.
  • Diabetes mellitus and other disorders of carbohydrate metabolism due to the high sugar content.
  • Excess body weight and obesity.
  • Pregnancy and breastfeeding (lactation).

Overdose Symptoms and Recommended Management Procedures

Symptoms of overdose may include nausea, vomiting, abdominal pain, and diarrhea.

In severe cases, lethargy, metabolic acidosis, and hepatic necrosis may occur. Seek immediate medical attention in case of suspected overdose.

Treatment is symptomatic and supportive. Gastric lavage may be indicated if performed soon after ingestion.

Dispensing Status

Available to the public through pharmacy networks and specialized stores, departments of the trading network.

Storage Conditions

Store in a dry place at a temperature from 0°C (32°F) to +25°C (77°F).

Shelf Life

Shelf life – 8 months.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS